Ultra-High Optical Purity Icon
D-LDH knockout ensures >99.5% L-LA, meeting the highest standards for PLA synthesis.
L-Lactic Acid (L-LA) is a key building block for polylactic acid (PLA) bioplastics used in packaging and textiles. High-strength, high-performance PLA requires L-LA with extremely high optical purity (>99% L-isomer). The challenge is that fermentation often produces both L- and D-lactic acid isomers (racemic mixture) . Additionally, the low pH required for fermentation inhibits cell growth, limiting yield, and the traditional neutralization method leads to high cost of separation and purification due to salt formation .
CD Biosynsis offers a comprehensive metabolic engineering solution to produce L-LA with high optical purity and efficient fermentation. Our strategy includes: Genetic Engineering: Knockout the D-Lactate Dehydrogenase (D-LDH) gene in the strain to ensure L-isomer purity . This eliminates the formation of the D-isomer. We further employ Engineering Tolerance: Modify cell membranes or introduce Efflux pumps to enhance tolerance to low pH and high product concentration . This enables efficient fermentation without costly base addition. Finally, we consider Host Switching: Utilize robust, non-nutritionally demanding hosts like engineered yeasts (e.g., S. cerevisiae) which naturally tolerate low pH and can utilize a wider range of substrates including xylose and lignocellulosic sugars.
Get a QuoteIndustrial L-Lactic Acid production faces these key challenges:
A successful solution must provide high optical purity (>99.5%), high productivity at low pH, and simplified downstream processing.
CD Biosynsis utilizes metabolic engineering to optimize L-Lactic Acid production:
D-LDH Gene Knockout for Optical Purity
Permanently inactivate the gene encoding D-LDH in the host strain to force 100% production of the L-isomer, meeting PLA standards.
Low pH and Product Tolerance Engineering
We modify cell membrane composition (e.g., fatty acid profile) and introduce Efflux pumps to actively expel lactic acid and maintain internal pH, enabling fermentation at low external pH (pH 3.0).
Host Switching and Substrate Expansion
We utilize robust yeasts (e.g., S. cerevisiae or C. glabrata) naturally tolerant to low pH. We engineer them to utilize low-cost feedstocks (xylose) and lignocellulosic hydrolysates.
Maximize L-Lactate Dehydrogenase Activity (L-LDH)
We overexpress and optimize the L-LDH gene to rapidly convert pyruvate to L-LA, maximizing carbon flux and titer.
This integrated approach solves the purity, pH inhibition, and downstream separation problems simultaneously.
Our L-Lactic Acid engineering service is dedicated to pursuing the following production goals:
Ultra-High Optical Purity Icon
D-LDH knockout ensures >99.5% L-LA, meeting the highest standards for PLA synthesis.
Low-pH Fermentation Icon
Tolerance engineering allows production at pH 3.0-3.5, avoiding base neutralization and salt formation.
Simplified Downstream Processing Icon
Low pH fermentation means producing free acid directly , eliminating gypsum waste and complex acidification steps. [Image of Cost Reduction Icon]
Low-Cost Substrate Utilization Icon
Using engineered yeast hosts allows for the efficient use of lignocellulosic hydrolysates (xylose and arabinose) to reduce raw material cost.
High Titer and Productivity Icon
Tolerance engineering and L-LDH optimization leads to high fermentation performance under industrial conditions.
We deliver a bio-based, cost-effective, and environmentally cleaner route for L-Lactic Acid production.
Our L-Lactic Acid strain engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product quality attributes.
Explore the potential for a cost-effective, high-purity L-Lactic Acid supply. CD Biosynsis provides customized strain and process engineering solutions:
Why is high optical purity of L-Lactic Acid critical for PLA?
PLA is a semicrystalline polymer whose properties (strength, heat resistance and crystallinity) are highly dependent on the purity of the monomer. The presence of the D-isomer (even a few percent) acts as an impurity, disrupting the crystal lattice formation and resulting in a brittle or low-quality PLA product.
How does D-LDH knockout ensure purity?
Lactic Acid isomers are produced by L- and D-Lactate Dehydrogenase (LDH) enzymes, which convert pyruvate to the respective isomer. By permanently deleting the D-LDH gene from the host genome, the cell retains only the ability to produce the L-isomer, guaranteeing near-perfect optical purity.
Why is producing free acid at low pH more cost-effective ?
Traditional neutralization requires adding base (e.g., lime) to maintain growth-friendly pH, forming lactate salt. Later, acid (e.g., sulfuric acid) is needed to free the LA, producing gypsum waste (CaSO4) . Fermenting directly at low pH (pH 3.0) avoids both the neutralization and acidification steps, drastically simplifying downstream and eliminating waste.
How do you enhance acid tolerance in yeast hosts?
Yeasts like S. cerevisiae are naturally more acid-tolerant than bacteria. We further engineer this tolerance by modifying the cell wall and membrane to reduce acid permeability and by introducing or overexpressing efflux pumps that actively remove lactic acid from the cytosol , maintaining a near-neutral internal pH for cell survival.
What is the estimated project timeline?
A project involving D-LDH knockout, L-LDH overexpression, and tolerance engineering in a yeast host typically requires 24-32 weeks for final strain delivery and performance validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.